Gene content    
SMAD4 ( by HUGO)
SMAD Family Member 4
Tumor suppressor gene
SMAD Family Member 4
MADH4
DPC4
Deletion Target In Pancreatic Carcinoma 4
MAD Homolog 4
JIP
MYHRS
MAD
Mothers Against Decapentaplegic Homolog 4 (Drosophila)
SMAD
Mothers Against DPP Homolog 4 (Drosophila)
Deleted In Pancreatic Carcinoma Locus 4
Mothers Against Decapentaplegic Homolog 4
Mothers Against Decapentaplegic
Drosophila
Homolog Of
4
SMAD
Mothers Against DPP Homolog 4
Smad4
hSMAD4
Mothers Against DPP Homolog 4
SMAD 4
NCBI: 18q21.1    Ensembl: 18q21.2
SMAD4_HUMANSize: 552 amino acidsMass: 60439 Da

  • Subunit: Interacts with CITED2 (By similarity). Monomer; in the absence of TGF-beta activation. Heterodimer; on TGF-beta activation. Composed of two molecules of a C-terminally phosphorylated R-SMAD molecule, SMAD2 or SMAD3, and one molecule of SMAD4 to form the transcriptional active SMAD2/SMAD3-SMAD4 complex. Found in a ternary complex composed of SMAD4, STK11/LKB1 and STK11IP. Interacts with ATF2, COPS5, DACH1, MSG1, SKI, STK11/LKB1, STK11IP and TRIM33. Interacts with ZNF423; the interaction takes place in response to BMP2 leading to activation of transcription of BMP target genes. Interacts with ZNF521; the interaction takes place in response to BMP2 leading to activation of transcription of BMP target genes. Interacts with USP9X. Interacts (via the MH1 and MH2 domains) with RBPMS. Interacts with WWTR1 (via coiled-coil domain). Component of the multimeric complex SMAD3/SMAD4/JUN/FOS which forms at the AP1 promoter site; required for syngernistic transcriptional activity in response to TGF-beta. Interacts with CITED1. Interacts with PDPK1 (via PH domain) (By similarity). Interacts with VPS39; this interaction affects heterodimer formation with SMAD3, but not with SMAD2, and leads to inhibition of SMAD3-dependent transcription activation. Interactions with VPS39 and SMAD2 may be mutually exclusive 6 PDB 3D structures from [IMAGE] and Proteopedia [IMAGE] for SMAD4: 1DD1 (3D) [IMAGE] 1G88 (3D) [IMAGE] 1MR1 (3D) [IMAGE] 1U7F (3D) [IMAGE] 1U7V (3D) [IMAGE] 1YGS (3D) [IMAGE]
  • Function:
    UniProtKB/Swiss-Prot Summary: SMAD4_HUMAN, Q13485 Function: Common SMAD (co-SMAD) is the coactivator and mediator of signal transduction by TGF-beta (transforming growth factor). Component of the heterotrimeric SMAD2/SMAD3-SMAD4 complex that forms in the nucleus and is required for the TGF-mediated signaling. Promotes binding of the SMAD2/SMAD4/FAST-1 complex to DNA and provides an activation function required for SMAD1 or SMAD2 to stimulate transcription. Component of the multimeric SMAD3/SMAD4/JUN/FOS complex which forms at the AP1 promoter site; required for syngernistic transcriptional activity in response to TGF-beta. May act as a tumor suppressor. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator Gene Ontology (GO): Selected molecular function terms (see all 17): About this table GO ID Qualified GO term Evidence PubMed IDs GO:0000987 core promoter proximal region sequence-specific DNA binding IDA 18832382 GO:0000988 contributes to protein binding transcription factor activity IDA 18832382 GO:0001076 RNA polymerase II transcription factor binding transcription factor activity IEA -- GO:0001085 RNA polymerase II transcription factor binding IEA -- GO:0003677 contributes to DNA binding IDA 9389648 [IMAGE] Find genes that share ontologies with SMAD4 About GenesLikeMe Phenotypes: 6 GenomeRNAi human phenotypes for SMAD4: Increased S DNA content, incre Increased mitotic index Increased sensitivity to pacli S arrest Synthetic lethal with gemcitab Upregulation of Wnt/beta-caten Selected MGI mutant phenotypes (inferred from 17 alleles[IMAGE]) (MGI details for Smad4) (see all 19): behavior/neurological cardiovascular system cellular digestive/alimentary embryogenesis endocrine/exocrine gland growth/size/body hematopoietic system homeostasis/metabolism immune system integument liver/biliary system mortality/aging muscle nervous system [IMAGE] Find genes that share phenotypes with SMAD4 About GenesLikeMe Animal Models: MGI mouse knock-outs for SMAD4: Smad4tm1.1Rob Smad4tm1.1Rdp Smad4tm2.1Rob Smad4tm2.2Cxd Smad4tm1Cxd Smad4tm1Mak Smad4tm2Cxd Smad4tm1Mmt [IMAGE] inGenious Targeting Laboratory: Let us create your new Knockout/Knockin mouse model for SMAD4 [IMAGE] inGenious Targeting Laboratory: Contact us about creating complex and humanized mouse models for SMAD4 [IMAGE] genOway customized KO model: permanent, tissue-specific or time-controlled inactivation for SMAD4 [IMAGE] genOway customized Knockin model: humanization, point mutation, expression monitoring, etc. for SMAD4 Transcription Factor Targeting: [IMAGE] Targeting motifs: HOMER Transcription Factor Regulatory Elements motif viewer [IMAGE] Consensus sequence: VBSYGTCTGG miRNA Products: miRTarBase miRNAs that target SMAD4: hsa-mir-155-5p (MIRT020774), hsa-mir-19b-3p (MIRT031156), hsa-mir-182-5p (MIRT007306), hsa-mir-130a-3p (MIRT007144), hsa-mir-454-3p (MIRT007251), hsa-mir-301a-3p (MIRT007250), hsa-mir-483-3p (MIRT004118), hsa-mir-20a-5p (MIRT005631), hsa-mir-93-5p (MIRT028004), hsa-mir-224-5p (MIRT006527), hsa-mir-26a-5p (MIRT003803), hsa-mir-146a-5p (MIRT006209), hsa-mir-18a-5p (MIRT004736), hsa-mir-92a-3p (MIRT005632), hsa-mir-17-5p (MIRT005629), hsa-mir-186-5p (MIRT021160), hsa-mir-130b-3p (MIRT020189), hsa-mir-199a-5p (MIRT007013), hsa-mir-19a-3p (MIRT005630) [IMAGE] Block miRNA regulation of human, mouse, rat SMAD4 using miScript Target Protectors [IMAGE] Selected qRT-PCR Assays for microRNAs that regulate SMAD4 (see all 195): hsa-miR-411* hsa-miR-106a hsa-miR-146a hsa-miR-605 hsa-miR-519a hsa-miR-3921 hsa-miR-298 hsa-miR-130b [IMAGE] SwitchGear 3'UTR luciferase reporter plasmid: SMAD4 3' UTR sequence Inhib. RNA Products: [IMAGE] OriGene RNAi products in human, mouse, rat for SMAD4 [IMAGE] Predesigned siRNA for gene silencing in human, mouse, rat SMAD4 Gene Editing Products: [IMAGE] DNA2.0 Custom Protein Engineering Service for SMAD4 Clone Products: [IMAGE] OriGene clones in human, mouse for SMAD4 (see all 7) OriGene ORF clones in mouse, rat for SMAD4 OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling [IMAGE] GenScript: all cDNA clones in your preferred vector: SMAD4 (NM_005359) [IMAGE] Sino Biological Human cDNA Clone for SMAD4 [IMAGE] DNA2.0 Custom Codon Optimized Gene Synthesis Service for SMAD4 [IMAGE] Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat SMAD4 [IMAGE] Addgene plasmids for SMAD4 [IMAGE] Cell Line Products: [IMAGE] GenScript Custom overexpressing Cell Line Services for SMAD4 [IMAGE] Browse ESI BIO Cell Lines and PureStem Progenitors for SMAD4 [IMAGE] In Situ Assay Products: [IMAGE] Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for SMAD4 Flow Cytometry Products: [IMAGE] eBioscience FlowRNA Probe Sets (VA1-12103) for SMAD4 [IMAGE]
  • Similarity:
    Belongs to the dwarfin/SMAD family
                          
    Contains 1 MH1 (MAD homology 1) domain
                          
    Contains 1 MH2 (MAD homology 2) domain [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR001132SMAD_dom_Dwarfin-typeDwarfin proteinFamily
    IPR003619MAD_homology1_Dwarfin-typeDwarfin protein, ADomain
    IPR008984SMAD_FHA_domainSMAD/FHADomain
    IPR013019MAD_homology_MH1MAD homology, MH1Domain
    BlocksIPB001132Dwarfin proteinDwarfin protein

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process BMP signaling pathway IDA GOA 9389648
    intracellular signal transduction IDA GOA 9389648
    negative regulation of cell growth IDA GOA 8774881
    negative regulation of transcription, DNA-templated IDA GOA 8774881
    positive regulation of BMP signaling pathway IMP GOA 19366699
    positive regulation of transcription from RNA polymerase II promoter IDA GOA 18832382
    positive regulation of transcription, DNA-templated IDA GOA 8774881
    positive regulation of transforming growth factor beta receptor signaling pathway IDA GOA 19328798
    regulation of transforming growth factor beta receptor signaling pathway IMP GOA 8774881
    regulation of transforming growth factor beta2 production IMP GOA 12411310
    response to hypoxia IMP GOA 12411310
    response to transforming growth factor beta IDA GOA 9707553
    SMAD protein complex assembly IDA GOA 10823886
    SMAD protein signal transduction IDA GOA 9707553
    transforming growth factor beta receptor signaling pathway IDA GOA 9389648
    Cellular Component activin responsive factor complex IDA GOA 9389648
    SMAD protein complex IDA GOA 18832382
    transcription factor complex IDA GOA 17438144
    transcription factor complex IPI GOA 12374795
    Molecular Function contributes_to DNA binding IDA GOA 9389648
    contributes_to protein binding transcription factor activity IDA GOA 18832382
    contributes_to sequence-specific DNA binding IDA GOA 10823886
    contributes_to sequence-specific DNA binding transcription factor activity IDA GOA 10823886
    core promoter proximal region sequence-specific DNA binding IDA GOA 18832382
    I-SMAD binding IPI GOA 9256479
    identical protein binding IPI GOA 9111321
    protein binding IPI GOA 11278302
    protein homodimerization activity IPI GOA 8774881
    R-SMAD binding IPI GOA 8774881
    transcription regulatory region DNA binding IDA GOA 17438144
    transforming growth factor beta receptor, common-partner cytoplasmic mediator activity IDA GOA 9389648

    Disorder & Mutation    
    Source Disease
    SWISS-PROTJuvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JP/HHT) [MIM:175050]: JP/HHT syndrome phenotype consists of the coexistence of juvenile polyposis (JIP) and hereditary hemorrhagic telangiectasia (HHT) [MIM:187300] in a single individual. JIP and HHT are autosomal dominant disorders with distinct and non-overlapping clinical features. The former, an inherited gastrointestinal malignancy predisposition, is caused by mutations in SMAD4 or BMPR1A, and the latter is a vascular malformation disorder caused by mutations in ENG or ACVRL1. All four genes encode proteins involved in the transforming-growth-factor-signaling pathway. Although there are reports of patients and families with phenotypes of both disorders combined, the genetic etiology of this association is unknown. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTPancreatic cancer (PNCA) [MIM:260350]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. Note=The gene represented in this entry may be involved in disease pathogenesis
    SWISS-PROTJuvenile polyposis syndrome (JPS) [MIM:174900]: Autosomal dominant gastrointestinal hamartomatous polyposis syndrome in which patients are at risk for developing gastrointestinal cancers. The lesions are typified by a smooth histological appearance, predominant stroma, cystic spaces and lack of a smooth muscle core. Multiple juvenile polyps usually occur in a number of Mendelian disorders. Sometimes, these polyps occur without associated features as in JPS; here, polyps tend to occur in the large bowel and are associated with an increased risk of colon and other gastrointestinal cancers. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTColorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. Note=The disease may be caused by mutations affecting the gene represented in this entry
    SWISS-PROTNote=SMAD4 variants may be associated with susceptibility to pulmonary hypertension, a disorder characterized by plexiform lesions of proliferating endothelial cells in pulmonary arterioles. The lesions lead to elevated pulmonary arterial pression, right ventricular failure, and death. The disease can occur from infancy throughout life and it has a mean age at onset of 36 years. Penetrance is reduced. Although familial pulmonary hypertension is rare, cases secondary to known etiologies are more common and include those associated with the appetite-suppressant drugs

    SMAD4 cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene